Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine

Author： Kurz M.A. Bullough D.A. Bugge C.J.L. Mullane K.M. Young M.A.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.322, Iss.2, 1997-03, pp. : 211-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acadesine, an adenosine-regulating agent with the potential for widespread indications

By Drew Brian G Kingwell Bronwyn A

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2137-2144

Informa Healthcare

Access to resources Recommend Favorite

Anesthetic Cardioprotection: The Role of Adenosine

Current Pharmaceutical Design, Vol. 20, Iss. 36, 2014-11 ,pp. : 5690-5695

Bentham Science Publishers

Access to resources Recommend Favorite

Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism

By Bradamante S. Barenghi L. Piccinini F. Bertelli A.A.E. De Jonge R. Beemster P. De Jong J.W.

European Journal of Pharmacology, Vol. 465, Iss. 1, 2003-03 ,pp. : 115-123

Elsevier

Access to resources Recommend Favorite

Acute Intravenous Infusion of an Adenosine Regulating Agent Improves Left Ventricular Function in Dogs with Advanced Heart Failure

By Wang Mengjun Gupta Ramesh Rastogi Sharad Kohli Smita Zhang Kefei Lanfear David Sabbah Hani

Cardiovascular Drugs and Therapy, Vol. 27, Iss. 6, 2013-12 ,pp. : 489-498

Springer Publishing Company

Access to resources Recommend Favorite

A novel adenosine receptor pharmacophore

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 729-732

Informa Healthcare

Access to resources Recommend Favorite